US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 72.930
  • +0.800+1.11%
Trading Apr 26 12:55 ET
7.68BMarket Cap-49952P/E (TTM)

Intra-Cellular Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
85.51%462.18M
50.41%131.51M
75.05%125.81M
99.96%110.13M
172.57%94.73M
204.91%249.13M
242.66%87.43M
232.64%71.87M
189.76%55.07M
123.09%34.76M
Operating revenue
85.51%462.18M
50.41%131.51M
75.05%125.81M
99.96%110.13M
172.57%94.73M
204.91%249.13M
242.66%87.43M
232.64%71.87M
189.76%55.07M
123.09%34.76M
Cost of revenue
65.07%33.75M
57.66%10.7M
56.05%9.13M
54.04%7.16M
113.98%6.75M
154.42%20.44M
167.35%6.79M
192.35%5.85M
127.94%4.65M
116.84%3.16M
Gross profit
87.34%428.43M
49.80%120.8M
76.74%116.68M
104.20%102.97M
178.42%87.98M
210.41%228.69M
250.98%80.65M
236.75%66.02M
197.19%50.42M
123.73%31.6M
Operating expense
19.40%587.81M
20.96%154.9M
20.34%146.39M
8.53%150.14M
30.80%136.37M
37.00%492.32M
17.50%128.06M
25.50%121.65M
60.67%138.35M
54.82%104.26M
Selling and administrative expenses
14.24%409.86M
10.66%104.72M
19.05%105.21M
0.70%101.01M
31.09%98.92M
31.61%358.78M
18.77%94.63M
25.36%88.38M
43.61%100.32M
43.50%75.46M
Research and development costs
33.72%180.14M
49.94%50.77M
24.87%41.55M
29.21%49.79M
30.92%38.02M
51.63%134.72M
14.95%33.86M
23.09%33.27M
122.79%38.54M
92.87%29.04M
Other operating expenses
-85.70%-2.2M
-36.01%-593K
---363K
-31.49%-664K
-138.59%-575K
43.58%-1.18M
-181.29%-436K
----
51.44%-505K
19.40%-241K
Operating profit
39.54%-159.38M
28.08%-34.1M
46.59%-29.71M
46.34%-47.18M
33.40%-48.39M
7.72%-263.63M
44.87%-47.41M
28.06%-55.63M
-27.16%-87.92M
-36.53%-72.66M
Net non-operating interest income expense
175.80%20.34M
76.20%5.97M
159.10%5.5M
243.18%4.53M
693.61%4.35M
370.41%7.38M
1,154.07%3.39M
439.95%2.12M
213.54%1.32M
13.22%548K
Non-operating interest income
175.80%20.34M
76.20%5.97M
159.10%5.5M
243.18%4.53M
693.61%4.35M
370.41%7.38M
1,154.07%3.39M
439.95%2.12M
213.54%1.32M
13.22%548K
Other net income (expense)
Income before tax
45.74%-139.04M
36.10%-28.13M
54.74%-24.22M
50.75%-42.65M
38.93%-44.04M
9.81%-256.25M
48.65%-44.03M
30.45%-53.51M
-26.02%-86.6M
-36.75%-72.11M
Income tax
10,500.00%636K
448K
4,200.00%43K
135K
100.00%10K
0.00%6K
0
104.35%1K
0
0.00%5K
Net income
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
-25.98%-86.6M
-36.74%-72.12M
Net income continuous Operations
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
-25.98%-86.6M
-36.74%-72.12M
Minority interest income
Net income attributable to the parent company
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
-25.98%-86.6M
-36.74%-72.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
-25.98%-86.6M
-36.74%-72.12M
Basic earnings per share
46.32%-1.46
33.33%-0.3
56.14%-0.25
51.09%-0.45
41.03%-0.46
22.29%-2.72
57.14%-0.45
40.00%-0.57
-8.24%-0.92
-20.00%-0.78
Diluted earnings per share
46.32%-1.46
33.33%-0.3
56.14%-0.25
51.09%-0.45
41.03%-0.46
22.29%-2.72
57.14%-0.45
40.00%-0.57
-8.24%-0.92
-20.00%-0.78
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 85.51%462.18M50.41%131.51M75.05%125.81M99.96%110.13M172.57%94.73M204.91%249.13M242.66%87.43M232.64%71.87M189.76%55.07M123.09%34.76M
Operating revenue 85.51%462.18M50.41%131.51M75.05%125.81M99.96%110.13M172.57%94.73M204.91%249.13M242.66%87.43M232.64%71.87M189.76%55.07M123.09%34.76M
Cost of revenue 65.07%33.75M57.66%10.7M56.05%9.13M54.04%7.16M113.98%6.75M154.42%20.44M167.35%6.79M192.35%5.85M127.94%4.65M116.84%3.16M
Gross profit 87.34%428.43M49.80%120.8M76.74%116.68M104.20%102.97M178.42%87.98M210.41%228.69M250.98%80.65M236.75%66.02M197.19%50.42M123.73%31.6M
Operating expense 19.40%587.81M20.96%154.9M20.34%146.39M8.53%150.14M30.80%136.37M37.00%492.32M17.50%128.06M25.50%121.65M60.67%138.35M54.82%104.26M
Selling and administrative expenses 14.24%409.86M10.66%104.72M19.05%105.21M0.70%101.01M31.09%98.92M31.61%358.78M18.77%94.63M25.36%88.38M43.61%100.32M43.50%75.46M
Research and development costs 33.72%180.14M49.94%50.77M24.87%41.55M29.21%49.79M30.92%38.02M51.63%134.72M14.95%33.86M23.09%33.27M122.79%38.54M92.87%29.04M
Other operating expenses -85.70%-2.2M-36.01%-593K---363K-31.49%-664K-138.59%-575K43.58%-1.18M-181.29%-436K----51.44%-505K19.40%-241K
Operating profit 39.54%-159.38M28.08%-34.1M46.59%-29.71M46.34%-47.18M33.40%-48.39M7.72%-263.63M44.87%-47.41M28.06%-55.63M-27.16%-87.92M-36.53%-72.66M
Net non-operating interest income expense 175.80%20.34M76.20%5.97M159.10%5.5M243.18%4.53M693.61%4.35M370.41%7.38M1,154.07%3.39M439.95%2.12M213.54%1.32M13.22%548K
Non-operating interest income 175.80%20.34M76.20%5.97M159.10%5.5M243.18%4.53M693.61%4.35M370.41%7.38M1,154.07%3.39M439.95%2.12M213.54%1.32M13.22%548K
Other net income (expense)
Income before tax 45.74%-139.04M36.10%-28.13M54.74%-24.22M50.75%-42.65M38.93%-44.04M9.81%-256.25M48.65%-44.03M30.45%-53.51M-26.02%-86.6M-36.75%-72.11M
Income tax 10,500.00%636K448K4,200.00%43K135K100.00%10K0.00%6K0104.35%1K00.00%5K
Net income 45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M-25.98%-86.6M-36.74%-72.12M
Net income continuous Operations 45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M-25.98%-86.6M-36.74%-72.12M
Minority interest income
Net income attributable to the parent company 45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M-25.98%-86.6M-36.74%-72.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M-25.98%-86.6M-36.74%-72.12M
Basic earnings per share 46.32%-1.4633.33%-0.356.14%-0.2551.09%-0.4541.03%-0.4622.29%-2.7257.14%-0.4540.00%-0.57-8.24%-0.92-20.00%-0.78
Diluted earnings per share 46.32%-1.4633.33%-0.356.14%-0.2551.09%-0.4541.03%-0.4622.29%-2.7257.14%-0.4540.00%-0.57-8.24%-0.92-20.00%-0.78
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg